Evidence map›Paper›PMID 26337832›Full record

ArticleHarm reduction journal2015

Cross-sectional assessments of participants' characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan.

Horacio Ruiseñor-Escudero, Alexander Vu, Andrea L Wirtz, Itziar Familiar-Lopez, Mark Berry, Iliassou Mfochive, Cyrus Engineer, Ahmad Farhad, Senop Tschakarjan, Ernst Wisse and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Harm reduction journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Understanding injecting drug use in Afghanistan: A scoping review.Substance abuse treatment, prevention, and policy · 2022
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Horacio Ruiseñor-EscuderoDepartment of Psychiatry, Michigan State University, College of Ostheopathic Medicine, 965 E Fee Hall Suite A227, Lansing, MI, 48824, USA. ruiseore@msu.edu.
Alexander VuDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD, 21205, USA.
Andrea L WirtzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Center for Public Health and Human Rights, 615 N Wolfe Street, Baltimore, MD, 21205, USA.
Itziar Familiar-LopezDepartment of Psychiatry, Michigan State University, College of Ostheopathic Medicine, 965 E Fee Hall Suite A227, Lansing, MI, 48824, USA.
Mark BerryDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD, 21205, USA.
Iliassou MfochiveDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD, 21205, USA.
Cyrus EngineerDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD, 21205, USA.
Ahmad FarhadMedecins du Monde, Kabul, Afghanistan.
Senop TschakarjanMedecins du Monde, Kabul, Afghanistan.
Ernst WisseMedecins du Monde, Kabul, Afghanistan.
Feda M PaikanNational AIDS Control Program, Kabul, Afghanistan.
Gilbert BurnhamDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD, 21205, USA.
Johns Hopkins University · USInstitut des Mondes Africains · FRMichigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKabul has over 12,000 people who inject drugs (PWID), most of them heroin users, and opioid substitution therapy has recently been introduced as an effective method to reduce opioid use. We aimed to evaluate a pilot Opioid Substitution Therapy Pilot Program (OSTPP) in Kabul, Afghanistan, particularly to (1) describe characteristics of the participants enrolled in the program and (2) identify factors associated with client retention in the OSTPP.

findingsTwo cross-sectional surveys evaluated participants attending the OSTPP at baseline (n = 83) and 18 months after (n = 57). Questionnaires assessed socio-demographic, drug use behavior, and general and mental health factors. After 18 months, 57 participants remained in the OSTPP. Participants lost to follow-up were younger (p < 0.01) and married (p < 0.01) and had no family contact (p < 0.01). Participants at 18 months reported no criminal activity in the last month and only two (3.5 %) reported heroin use in the last month, constituting significant decreases from baseline.

conclusionsWhile preliminary results are promising, further evaluation is needed to determine the feasibility of implementing OSTPP in this setting and effectiveness in reducing injection risk behaviors in Afghanistan.

Indexed as

Lost to Follow-UpAdolescentAdultAfghanistanCross-Sectional StudiesFemaleHumansMaleOpiate Substitution TreatmentOpioid-Related DisordersPilot ProjectsSubstance Abuse, IntravenousSurveys and QuestionnairesYoung Adult

Identifiers

PMID26337832
PMCPMC4559065
OpenAlexW1942413087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.